<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-21T02:37:35Z</responseDate><request verb="GetRecord" identifier="oai:macsphere.mcmaster.ca:11375/13101" metadataPrefix="dim">https://prod-ms-be.lib.mcmaster.ca/server/oai/request</request><GetRecord><record><header><identifier>oai:macsphere.mcmaster.ca:11375/13101</identifier><datestamp>2026-09-24T05:12:07Z</datestamp><setSpec>com_11375_271</setSpec><setSpec>col_11375_272</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="advisor" lang="en_US">Muller, William J.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Hutchinson, John N.G.</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="department" lang="en_US">Biology</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2014-06-18T17:02:28Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2014-06-18T17:02:28Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="created" lang="en_US">2009-08-27</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2003</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">opendissertations/793</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">1805</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="other" lang="en_US">975089</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">http://hdl.handle.net/11375/13101</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://doi.org/10.71548/22259</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">&lt;p>Activation of Akt-1 by the phosphatidylinositol 3'-OH kinase (PI3K) results in the inhibition of pro-apoptotic signals and the promotion of survival and proliferation signals. Transgenic mice expressing polyomavirus middle T antigen in the mammary epithelium rapidly develop multifocal metastatic mammary tumors whereas transgenic mice expressing a mutant middle T antigen de-coupled from the PI3K (MTY315/322F) develop extensive mammary gland hyperplasias that are highly apoptotic. Mammary tumorigenesis in this mutant strain is further associated with Akt-1 activation and overexpression of receptor tyrosine kinases (RTKs) known to activate the PI3K. To directly assess the role of Akt-1 in mammary epithelial development and tumorigenesis, we generated transgenic mice expressing constitutively active Akt-1 (HAPKB308D473D or Akt-DD). Although expression of Akt-DD interferes with normal mammary gland involution, tumors were not observed in these strains. Importantly, co-expression of Akt-DD with MTY315/322F results in phosphorylation of the FKHR transcription factor and post-transcriptional up-regulation of cyclin DI levels. In support of a broader role for Akt-1 in RTK-mediated mamary tumorigenesis, bi-transgenics carrying MMTV/Akt-DD and MMTV/activated ErbB-2 develop multifocal mammary tumors with a significatnyl shorter latency period than mice expressing activated ErbB-2 alone. The acceleration of mammary tumor progression correlated with enhanced differentiation, increased cellular proliferation, post-transcriptionally elevated Cyclin D1 levels and phosphorylation of retinoblastoma protein. Importantly, we did not observe an associated restoration of wildtype metastasis levels in either of these bi-transgenic strains and actually witnessed metastasis levels in either of these bi-transgenic strains and actually witnessed metastatic reductions in the Akt-DDxErbB-2 bi-transgenics. These observations suggest that activation of Akt-1 can contribute to tumor progression by providing an important cell survival signal and may in certain cases act to prevent metastatic progression through the promotion of a mammary differentiation program.&lt;/p></dim:field>
   <dim:field mdschema="dc" element="description" qualifier="degree" lang="en_US">Doctor of Philosophy (PhD)</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Biology</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">Biology</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">The Role of the Alt-1 Serine/Threonine Kinase in Mammary Gland Development and Tumorigenesis</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">thesis</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
</dim:dim></metadata></record></GetRecord></OAI-PMH>